APTOSE BIOSCIENCES INC has a total of 48 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CORCEPT THERAPEUTICS INCORPORATED, TRINE PHARMACEUTICALS INC and ACCENDATECH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | China | 5 | |
#5 | Republic of Korea | 5 | |
#6 | Australia | 4 | |
#7 | Canada | 3 | |
#8 | Taiwan | 2 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Basic materials chemistry | |
#7 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Special acyclic compounds | |
#6 | Preservation of human bodies | |
#7 | Peptides | |
#8 | Foods | |
#9 | Locks | |
#10 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Rice William G | 25 |
#2 | Young Aiping H | 10 |
#3 | Huesca Mario | 9 |
#4 | Lee Yoon | 9 |
#5 | Cho Joong Myung | 8 |
#6 | Hong Yongrae | 8 |
#7 | Nedunuri Venkata | 7 |
#8 | Howell Stephen | 7 |
#9 | Tsai Cheng-Yu | 7 |
#10 | Peralta Robert | 7 |
Publication | Filing date | Title |
---|---|---|
WO2020113216A1 | Combination therapy with 2,3-dihydro-isoindole-1-one compounds and methods for treating patients with various mutations | |
KR20200096914A | Aryl imidazole for cancer treatment | |
CA3054196A1 | Methods for treating patients with hematologic malignancies | |
KR20190135464A | Fused pyrimidines as BRD4 and JAK2 dual inhibitors and methods of use thereof | |
CN105764511A | Compositions and methods for treating cancers | |
US2016031883A1 | 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer |